RemedyBio’s CEO Dan Crowley will be speaking at the 3rd Annual Cell Therapies in London…
Remedy BiologicsFebruary 2, 2024
3rd Annual Allogeneic Cell Therapies Summit
RemedyBio’s CEO Dan Crowley will be speaking at the 3rd Annual Cell Therapies in London on January 30th & 31st.…
Read More
RemedyBio’s CEO Dan Crowley will be chairing a panel discussion ‘How single cell phenotyping will…
Remedy BiologicsSeptember 25, 2023
RemedyBio’s CEO Dan Crowley will be speaking at the plenary panel session Spotlight on Irish…
Remedy BiologicsMay 11, 2023
Dublin, Ireland, December 12, 2022 - RemedyBio, an immune therapy discovery and development biotech company,…
Remedy BiologicsDecember 13, 2022
EU Programme funded under Horizon Europe Developing a ground-breaking inhaled gene therapy for lung cancer…
Remedy BiologicsDecember 6, 2022
Primary tissue material to be supplied by Brigham and Women’s Hospital and Dana-Farber Cancer Institute…
Remedy BiologicsOctober 10, 2022
Strengthening target and drug discovery expertise with the addition of Dr Christopher Miller Dublin, Ireland,…
Remedy BiologicsSeptember 8, 2022
Initial focus on patient derived TILs in gynaecological cancers RemedyBio will collaborate with researchers at…
Remedy BiologicsJune 6, 2022
RemedyBio today announces a new collaborative research project with the Thoracic Oncology Research Group (TORG) at…
Remedy BiologicsMay 27, 2022
The European Innovation Council Fund supports RemedyBio with an €8M investment facility adding to EIC’s…
Remedy BiologicsMay 27, 2022
RemedyBio today announced that Mr. Ashley Nagle has joined the company as Vice President, Business Development. Mr.…
Remedy BiologicsMay 27, 2022
RemedyBio is delighted to announce the success of the HEALED Consortium in securing DTIF support…
Remedy BiologicsMay 27, 2022
RemedyBio is pleased to announce that it has completed its move to its new laboratory…
Remedy BiologicsMay 27, 2022
Irish Biotechnology company RemedyBio has received a multi-million euro funding award from the European Innovation…
Remedy BiologicsMay 27, 2022
RemedyBio is now supported through funding from the Irish Research Council to investigate patient stratification…
Remedy BiologicsMay 27, 2022
RemedyBio's CSO Dr. Paul Leonard is leading an independent validation study of commercially available COVID-19…
Remedy BiologicsMay 27, 2022
Leading experts in immunology, immuno-oncology and cancer cell therapies bring their expertise to advance development…
Remedy BiologicsMay 27, 2022
Leading experts in immunology, immuno-oncology and cancer cell therapies bring their expertise to advance development…
Remedy BiologicsMay 25, 2022
RemedyBio today announces a new collaborative research project with the Thoracic Oncology Research Group (TORG) at…
Remedy BiologicsNovember 24, 2021
The European Innovation Council Fund supports RemedyBio with an €8M investment facility adding to EIC’s…
Remedy BiologicsJuly 20, 2021
SUPPORTED BY
